Inclusion criteria comprised peer-reviewed original articles and reviews published between 2010 and 2025 that focus on NF-κB signaling in GBM biology, glioma stem cells, tumor microenvironment, or therapeutic strategies. The gene discussed is NFKB1; the disease is glioblastoma.